Fidelta

Home
Croatia
Zagreb
Fidelta

Integrated drug discovery at Fidelta is driven by our determination to deliver efficacious, safe and differentiated preclinical candidates.

Fidelta combines expertise in the areas of chemistry, pharmacology, ADME, pharmacokinetics and toxicology offering integrated discovery services to the biotech, pharmaceutical, agrochemical, food, cosmetic and chemical industries. At Fidelta, integrated drug discovery is driven by our determination to deliver EFFICACIOUS, SAFE and DIFFERENTIATED PRECLINICAL CANDIDATES. Our integrated drug discover

y platform is built upon:
• Our extensive experience in drug discovery, from target validation to early preclinical development
• A full range of in house drug discovery capabilities including chemistry, pharmacology, ADME, pharmacokinetics and toxicology
• Our therapeutic area expertise, targeting inflammation (and linked conditions in the fields of infection, oncology, metabolic disease) and antibacterials
• A strong emphasis on translational science, focusing on patients and disease-relevant test models/systems
• Our multidisciplinary team of high-performing bench scientists. Of particular note are the extensive AAALAC accredited in vivo capabilities giving the possibility to take projects all the way to the clinic. Specialties

Preclinical drug discovery services, Integrated drug discovery, Efficacy & Safety, AAALAC, Macrocyclic chemistry

29/03/2018

We're hiring. If you are up to the challenge of joining our entrepreneurial team take a look at our current openings at http://www.fidelta.eu/about/jobs/.

Current openings

22/01/2018

Take a look at our current openings at http://www.fidelta.eu/about/jobs/. If you up to the challenge of joining our entrepreneurial team, please send your application to [email protected].

Current openings

12/04/2017

Congratulations to our very own Mirjana Bukvic for being named the 2017 Young Medicinal Chemist in Industry by the European Federation for Medicinal Chemistry!
http://www.efmc.info/content.php?langue=english&cle_menus=1201086324

The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scienti...

30/11/2016

Adrijana Vinter appointed new Managing Director of Fidelta
Fidelta, a collaborative drug discovery company, has appointed Dr Adrijana Vinter, current head of business development, as new managing director of the company.
Adrijana will commence her new role from January 1st 2017, succeeding Dr Phil Dudfield who is retiring.
Adrijana obtained her PhD in Chemistry at the University of Zagreb in the field of new macrolide antibiotics and started her career in PLIVA 14 years ago working initially as a scientist. She obtained an MBA at Cotrugli Business School, Croatia, before moving into Business Development with the creation of Fidelta. She has successfully engineered and overseen the development of the Fidelta revenue stream resulting in significant year on year growth.
Under the new leadership, Fidelta’s operations will continue seamlessly through delivering high quality services to the clients.
http://www.fidelta.eu/resources/news/adrijana-vinter-appointed-new-managing-director-fidelta/

30/05/2014

Yesterday, around 6pm..

Address

Prilaz Baruna Filipovića 29
Zagreb
10000

Website

http://www.fidelta.eu/

Alerts

Be the first to know and let us send you an email when Fidelta posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.